Drug Type Oncolytic virus |
Synonyms- |
Target |
Action- |
Mechanism CDK inhibitors(Cyclin-dependent kinase (CDK) family inhibitors), PARP inhibitors(Poly (ADP-Ribose) polymerase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Infectious Diseases | Discovery | - | 04 Jul 2019 | |
| Mouth and Tooth Diseases | Discovery | - | 04 Jul 2019 | |
| Neoplasms | Discovery | - | 04 Jul 2019 | |
| Skin Diseases | Discovery | - | 04 Jul 2019 |





